I am a nurse practitioner with Hepatology and Gastroenterology at University of North Carolina at Chapel Hill. I focus on inpatient care of patients with liver disease. I have been in my role since 2009, and help to educate residents, medical students and APP students on the care of liver patients. (sorry, I don't currently have a head shot, so just putting a nice picture of some trees. I'll try and get a headshot)
Jessica Wisocky is an accomplished Nurse Practitioner who has dedicated her career to caring for underserved and marginalized communities. She holds a Master of Science in Nursing from Simmons College and a Bachelor of Science from the University of New Hampshire with a double major of Biochemistry and Women's Studies and minor of Race/Power/Culture.
Dr. Cecilia Dueñas is a bilingual Spanish/English Latina Clinical Psychologist, mother of two, and wife based in Southern California. Diagnosed with Primary Biliary Cholangitis (PBC) in 2021 after more than six years of undiagnosed symptoms and healthcare inequities, she turned her personal journey into a mission to advocate for patients facing rare liver diseases and health disparities.
Jon advocates for those living with liver disease as a result of Alcohol Use Disorder. More specifically, his focus is on those who suffer from ACLF of which he is a thankful survivor because of transplant. He also advocates for LatinX and LGTBQ communities who may become marginalized by liver disease because of its stigma. Jon is a semi-retired Fintech executive who takes great pride in being both a plant and dog dad.
Dr. Norah Terrault is a transplant hepatologist, the Neil Kaplowitz Professor of Medicine and Chief of Gastrointestinal and Liver Diseases Division at the Keck School of Medicine of University of Southern California in Los Angeles, California.
Lorrinda Gray-Davis is a liver transplant recipient, author, and President of Transplant Recipients International Organization (TRIO). She serves as Vice Chair of the OPTN Patient Affairs Committee and is a passionate advocate for transplant equity. Her story was recently featured in Cancer Today magazine.
Dr. Singal is a Professor of Medicine at UT Southwestern Medical Center and serves as Chief of Hepatology and Medical Director of the Liver Tumor Program. He has over 300 peer-reviewed original publications and has been awarded the Willis Maddrey Distinguished Chair in Liver Disease and Blue Faery Award for Excellence in Liver Cancer Research.
Ming-Lung Yu is a Chair Professor of Kaohsiung Medical University (KMU), Taiwan. He is also an adjunct chair professor of National Sun Yat-sen University(NSYSU). Professor Yu's research interests in the Hepatology, including epidemiology, natural course, risk stratification, treatment and prognosis of HBV and HCV, as well as MASLD, have led him to publish more than 500 scientific original and review articles.
Dr. Tung-Hung Su earned his M.D. degree from the National Taiwan University College of Medicine in 2001 and his Ph.D. from the Graduate Institute of Clinical Medicine at the same university in 2015. He has been an attending physician specializing in Hepatology and a Clinical Professor in the Department of Internal Medicine at National Taiwan University Hospital since 2024. From 2017 to 2019, he was a visiting scholar at Stanford University. Dr.
Dr. Anjana Pillai is a Professor of Medicine and Surgery at the University of Chicago. She is the Director of University of Chicago's multidisciplinary liver tumor program, interim Medical Director of the Transplant Institute and the Program Director for the ACGME accredited Transplant Hepatology Fellowship.